Arrhythmia Institute at Grandview, Birmingham, Alabama, USA.
Cardiac Arrhythmia Service, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
JACC Clin Electrophysiol. 2023 Aug;9(8 Pt 2):1543-1554. doi: 10.1016/j.jacep.2023.05.015. Epub 2023 May 18.
High-frequency, low-tidal-volume (HFLTV) ventilation is a safe and simple strategy to improve catheter stability and first-pass isolation during pulmonary vein (PV) isolation. However, the impact of this technique on long-term clinical outcomes has not been determined.
This study sought to assess acute and long-term outcomes of HFLTV ventilation compared with standard ventilation (SV) during radiofrequency (RF) ablation of paroxysmal atrial fibrillation (PAF).
In this prospective multicenter registry (REAL-AF), patients undergoing PAF ablation using either HFLTV or SV were included. The primary outcome was freedom from all-atrial arrhythmia at 12 months. Secondary outcomes included procedural characteristics, AF-related symptoms, and hospitalizations at 12 months.
A total of 661 patients were included. Compared with those in the SV group, patients in the HFLTV group had shorter procedural (66 [IQR: 51-88] minutes vs 80 [IQR: 61-110] minutes; P < 0.001), total RF (13.5 [IQR: 10-19] minutes vs 19.9 [IQR: 14.7-26.9] minutes; P < 0.001), and PV RF (11.1 [IQR: 8.8-14] minutes vs 15.3 [IQR: 12.4-20.4] minutes; P < 0.001) times. First-pass PV isolation was higher in the HFLTV group (66.6% vs 63.8%; P = 0.036). At 12 months, 185 of 216 (85.6%) in the HFLTV group were free from all-atrial arrhythmia, compared with 353 of 445 (79.3%) patients in the SV group (P = 0.041). HLTV was associated with a 6.3% absolute reduction in all-atrial arrhythmia recurrence, lower rate of AF-related symptoms (12.5% vs 18.9%; P = 0.046), and hospitalizations (1.4% vs 4.7%; P = 0.043). There was no significant difference in the rate of complications.
HFLTV ventilation during catheter ablation of PAF improved freedom from all-atrial arrhythmia recurrence, AF-related symptoms, and AF-related hospitalizations with shorter procedural times.
高频、小潮气量(HFLTV)通气是一种安全且简单的策略,可以改善肺静脉(PV)隔离过程中的导管稳定性和首次通过隔离。然而,这种技术对长期临床结果的影响尚未确定。
本研究旨在评估高频、小潮气量通气(HFLTV)与标准通气(SV)在阵发性心房颤动(PAF)射频消融中的急性和长期结果。
在这项前瞻性多中心登记研究(REAL-AF)中,纳入了使用 HFLTV 或 SV 进行 PAF 消融的患者。主要终点是 12 个月时无任何房性心律失常。次要终点包括手术特点、房颤相关症状和 12 个月时的住院情况。
共纳入 661 例患者。与 SV 组相比,HFLTV 组的手术时间(66[IQR:51-88]分钟 vs 80[IQR:61-110]分钟;P<0.001)、总射频时间(13.5[IQR:10-19]分钟 vs 19.9[IQR:14.7-26.9]分钟;P<0.001)和 PV 射频时间(11.1[IQR:8.8-14]分钟 vs 15.3[IQR:12.4-20.4]分钟;P<0.001)均较短。HFLTV 组首次通过 PV 隔离率更高(66.6% vs 63.8%;P=0.036)。12 个月时,HFLTV 组 216 例患者中有 185 例(85.6%)无任何房性心律失常,SV 组 445 例患者中有 353 例(79.3%)(P=0.041)。HFLTV 可使房性心律失常复发的绝对风险降低 6.3%,房颤相关症状发生率(12.5% vs 18.9%;P=0.046)和房颤相关住院率(1.4% vs 4.7%;P=0.043)降低。两组并发症发生率无显著差异。
在 PAF 导管消融中使用高频、小潮气量通气可缩短手术时间,提高无房性心律失常复发、房颤相关症状和房颤相关住院率。